Top compounds associated with response to NCR3LG1


Feature Type Standardized
Nominal ANOVA
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.014 0.7
mRNA KU 0060648 CTRPv2 pan-cancer AAC -0.014 0.7
mRNA Bosutinib CTRPv2 pan-cancer AAC 0.014 0.7
mRNA CIL41 CTRPv2 pan-cancer AAC -0.021 0.7
mRNA MLN2238 CTRPv2 pan-cancer AAC -0.013 0.7
mRNA istradefylline CTRPv2 pan-cancer AAC -0.021 0.7
mRNA Bortezomib CTRPv2 pan-cancer AAC 0.013 0.7
mRNA VAF-347 CTRPv2 pan-cancer AAC 0.018 0.7
mRNA Docetaxel CTRPv2 pan-cancer AAC 0.018 0.7
mRNA Vorinostat CTRPv2 pan-cancer AAC 0.012 0.7
Download CSV